<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02544919</url>
  </required_header>
  <id_info>
    <org_study_id>SMOF_NEURO_1</org_study_id>
    <nct_id>NCT02544919</nct_id>
  </id_info>
  <brief_title>Lipids and Neurological Complications in Liver Transplantation</brief_title>
  <acronym>LNCLT</acronym>
  <official_title>Impact of Pretreatment With Omega 3 Enriched Lipid Emulsion on Early Neurological Complications After Living Donor Liver Transplantation. A Randomized Controlled Trial&gt;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the impact of pretreatment of living donor liver transplantation recipients with
      SMOF lipid on the incidence and severity of post-transplantation neurological complications
      in patients receiving tacrolimus based immunosuppression protocol
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients included in the study will receive the same immuno-suppression protocol based on
      tacrolimus and mycophenolate mofetil after the induction immuno-suppression during the
      intra-operative period.

      Patients will have a full history taking and full neurological examination 48 hours prior to
      the designated operative date as a basal record.

      the control group will not receive any lipid infusions at all the treatment group will
      receive the study emulsion (SMOF lipid 20% - Fresenius Kabi) starting 48 hours before the
      planned surgery day and will continue to receive it for 5 post-operative days by intravenous
      infusion.

      During the post-operative period. patients will be assessed daily by full neurological
      examination as will as patient complaints (symptoms) related to neurological status for
      diagnosis of any neurological conditions (complications) that might arise during the study
      period.

      Data will be analysed compared to the basal value in each group and between both control and
      intervention groups using the appropriate statistical tests.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-transplant neurological complications</measure>
    <time_frame>5 post-operative days</time_frame>
    <description>Number of participants who develop neurological complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graft functions</measure>
    <time_frame>5 post-operative days</time_frame>
    <description>the laboratory parameters for graft functions in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>survival</measure>
    <time_frame>30 days</time_frame>
    <description>one month mortality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Neurological Complications</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No Intervention group: Patients do not receive any lipid emulsion of any type during the study period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMOF Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention Group: Patients receive 1 gm.kg.day-1 SMOFlipid for 48 hours before the operation and 5 days post-operatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SMOF lipid (SMOFLIPID) pre treatment</intervention_name>
    <description>Experimental Arm</description>
    <arm_group_label>SMOF Group</arm_group_label>
    <other_name>Experimental group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult living donor liver transplant recipients of either sex

        Exclusion Criteria:

          -  MELD score &gt; 30

          -  Retransplantation

          -  Budd Chiari syndrome

          -  Diabetes more than 10 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr M Yassen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MAnsoura Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amr M. Yassen, MD</last_name>
    <phone>01001497044</phone>
    <phone_ext>+2</phone_ext>
    <email>amryassen@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>waleed R Elsarraf, MD</last_name>
    <email>welsarraf@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Liver transplantation project - Gastroenterology surgical center - Mansoura university</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr M Yassen, MD</last_name>
      <phone>+201001497044</phone>
      <email>amryassen@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Waleed R Elsarraf, MD</last_name>
      <phone>+201222322727</phone>
      <email>welsarraf@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Amr M Yassen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed Elmorshidy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elrefaiee Kandil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Usama Elsaied, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Waleed R Elsarraf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2015</study_first_submitted>
  <study_first_submitted_qc>September 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2015</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amr Mohamed Yassen</investigator_full_name>
    <investigator_title>Professor of Anesthesia and Intensive care</investigator_title>
  </responsible_party>
  <keyword>SMOF</keyword>
  <keyword>neurological complications</keyword>
  <keyword>neurotoxicity</keyword>
  <keyword>liver transplantation</keyword>
  <keyword>Lipid emulsions</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

